AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Is argenx SE (NASDAQ:ARGX) Expanding Its Role in the Biotechnology Sector?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Rhumbline Advisers increased its stock position in argenx SE, reflecting ongoing institutional engagement.,Other hedge funds and financial institutions have also adjusted their holdings in argenx SE, reinforcing market interest.,The compan...
Why Are Institutional Firms Adjusting Their Holdings in Janux Therapeutics (NASDAQ:JANX)?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors, including Rhumbline Advisers, have made adjustments to their holdings in Janux Therapeutics.,Market activity reflects changes in financial participation, with several firms increasing or modifying positions.,Janux...
How Is Medtronic (NYSE:MDT) Adapting to Healthcare Market Changes?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Medtronic reported earnings that included an expense attributed to unusual items, affecting its profit figures.,The company’s financial structuring and revenue trends indicate continued engagement in the healthcare sector.,Market participa...
How Is Cybin Inc. (NYSE:CYBN) Advancing Psychedelic-Based Therapies?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Global Retirement Partners LLC acquired 5,250 shares in Cybin Inc., valued at around $46,000, as per SEC filings.,Recent research reports from Canaccord Genuity Group and HC Wainwright have adjusted price targets while maintaining positive...
Is U.S. Physical Therapy (NYSE:USPH) Maintaining Stability Amid Market Changes?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Principal Financial Group Inc. increased its stake in U.S. Physical Therapy, reflecting heightened institutional interest.,Market evaluations of the company vary, with diverse ratings assigned by research firms.,U.S. Physical Therapy maint...
What’s Behind the Recent Investment Moves in Pacira BioSciences (NASDAQ:PCRX)?
March 04, 2025 07:00 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors made notable adjustments to their Pacira BioSciences stakes, with some reducing holdings while others increased exposure.,Several equities experts updated their ratings and market perspectives on Pacira BioSciences...
Can Immunovant Redefine Biopharmaceutical Innovation?
March 04, 2025 06:26 PM AEDT| By Team Kalkine MediaHighlights,Immunovant (NASDAQ:IMVT) has received varied expert commentary.,Company executives engaged in significant share transactions.,Institutional investment positions underwent notable changes in the recent quarter.,Immunovant (NASDAQ:IMVT) oper...
Is National HealthCare Reshaping Healthcare Services?
March 04, 2025 06:26 PM AEDT| By Team Kalkine MediaHighlights,The stock has experienced notable fluctuations within a broad trading range.,A quarterly dividend underscores stable fiscal management.,Widespread institutional participation reinforces the company’s diversified service operations.,Nationa...
Senseonics (NYSE: SENS) Sees 56% Growth in Patient Base Following FDA Approval of Eversense® 365 CGM System
March 04, 2025 02:37 PM AEDT| By Team Kalkine MediaHighlights,FDA approval and US launch of Eversense® 365 CGM system drives 56% patient base growth.,Q4 2024 revenue reached $8.3 million, with a net loss of $15.5 million.,Senseonics projects $34-38 million in global revenue for 2025 with improved mar...
Why Is Mettler-Toledo International Inc. (NYSE:MTD) Gaining Attention in the Medical Instruments Sector?
March 04, 2025 04:37 AM AEDT| By Team Kalkine MediaHighlights,Institutional interest in Mettler-Toledo International Inc. has increased, with several firms adjusting their holdings.,The company operates within the medical instruments sector, focusing on precision instruments and laboratory equipment....
Is Bristol-Myers Squibb (NYSE:BMY) Adapting to Industry Changes?
March 04, 2025 04:11 AM AEDT| By Team Kalkine MediaHighlights,Bristol-Myers Squibb remains focused on pharmaceutical innovation and strategic developments.,The company continues expanding its pipeline with new treatments and acquisitions.,Industry competition and regulatory dynamics influence its ope...
Will the End of the Quiet Period Open New Coverage Opportunities?
March 03, 2025 05:22 PM AEDT| By Team Kalkine MediaHighlights:,Quiet period for Drugs Made in America Acquisition (NASDAQ:DMAAU) concludes on March tenth.,SEC regulations restrict research and public communications during this period.,Underwriters are set to initiate comprehensive research coverage p...
Is Astellas Pharma Reshaping Its Industry Impact?
March 03, 2025 05:22 PM AEDT| By Team Kalkine MediaHighlights,Significant drop in short interest recorded during February.,Maintains a substantial market capitalization with fluctuating share price.,Integrates key treatments such as XTANDI and XOSPATA into its pharmaceutical portfolio.,Astellas Pharm...
Has AddLife AB Short Interest Shifted Dramatically?
March 03, 2025 05:22 PM AEDT| By Team Kalkine MediaHighlights,Short interest dropped significantly over recent weeks,The stock maintained a steady price throughout the period,Operations span Labtech and Medtech segments in healthcare and pharmaceuticals,Within the expansive realm of healthcare and ph...
Which Biotechnology Firm Leads in Innovation and Financial Strength?
March 03, 2025 05:21 PM AEDT| By Team Kalkine MediaWhich Biotechnology Firm Leads in Innovation and Financial Strength?
Will Cabaletta Bio Outperform VectivBio in the Biotech Space?
March 03, 2025 05:20 PM AEDT| By Team Kalkine MediaWill Cabaletta Bio Outperform VectivBio in the Biotech Space?
Is Institutional Activity Shaping Geron Co.'s Course in a Volatile Environment?
March 02, 2025 09:26 PM AEDT| By Team Kalkine MediaHighlights,Notable institutional share adjustments from major financial institutions.,Financial performance matched revenue expectations amid challenging margins.,Clinical research on innovative therapeutics is progressing in advanced evaluations.,Ge...
Can Institutional Movements Reshape Walgreens Boots Alliance?
March 02, 2025 09:16 PM AEDT| By Team Kalkine MediaHighlights,The New York State Common Retirement Fund reduced its stake by nearly six and a half percent during the final quarter.,A significant portion of the company is now held by institutional and hedge fund investors.,Billions in revenue were rec...
Is Beam Therapeutics Shaping the Future of Precision Medicine?
March 02, 2025 09:10 PM AEDT| By Team Kalkine MediaHighlights:,Institutional investors adjusted their positions, with one adviser reducing holdings slightly while others recalibrated share allocations.,Executive share changes were executed by the Chief Executive Officer and a senior executive, reflec...
Can Shifting Institutional Interests Transform the Biopharma Landscape?
March 02, 2025 09:10 PM AEDT| By Team Kalkine MediaHighlights:,Institutional investment shifts observed with a reduction by one firm while other institutions increased their involvement.,Stock performance exhibits a wide range of trading levels over the past year.,Company focuses on addressing centra...
